{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:31:31Z","timestamp":1781055091706,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinimag.2025.110680","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:39:33Z","timestamp":1763771973000},"page":"110680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Investigation of the relationship between background parenchymal enhancement and breast cancer using 3.0\u00a0Tesla magnetic resonance imaging"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1609-6775","authenticated-orcid":false,"given":"S.","family":"Sekmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-2268","authenticated-orcid":false,"given":"N.","family":"Hursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-7344","authenticated-orcid":false,"given":"K.","family":"Panc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8981-171X","authenticated-orcid":false,"given":"F.","family":"Tasc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1130","key":"10.1016\/j.clinimag.2025.110680_bb0010","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br J Radiol"},{"issue":"suppl 10","key":"10.1016\/j.clinimag.2025.110680_bb0015","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/cncr.32887","article-title":"Breast cancer early detection: a phased approach to implementation","volume":"126","author":"Ginsburg","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110680_bb0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/sajc.sajc_104_18","article-title":"Role of magnetic resonance imaging in breast cancer management","volume":"7","author":"Radhakrishna","year":"2018","journal-title":"South Asian J Cancer"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.2019182947","article-title":"Breast MRI: state of the art","volume":"292","author":"Mann","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2025.110680_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinimag.2018.05.008","article-title":"Evaluation of association between degree of background parenchymal enhancement on MRI and breast cancer subtype","volume":"51","author":"Ha","year":"2018","journal-title":"Clin Imaging"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110680_bb0035","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.10.6272","article-title":"Background parenchymal enhancement on breast MRI: impact on diagnostic performance","volume":"198","author":"DeMartini","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110680_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-021-00566-8","article-title":"Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis","volume":"21","author":"Hu","year":"2021","journal-title":"BMC Med Imaging"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110680_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clinimag.2025.110680_bb0050","doi-asserted-by":"crossref","unstructured":"You C, Kaiser AK, Baltzer P, Krammer J, Gu Y, Peng W, Sch\u00f6nberg SO, Kaiser CG. The assessment of background parenchymal enhancement (BPE) in a high-risk population: what causes BPE? Transl Oncol 2018 Apr;11(2):243\u2013249. doi: https:\/\/doi.org\/10.1016\/j.tranon.2017.12.006. Epub 2018 Jan 28. PMID: 29413756; PMCID: PMC5884181.","DOI":"10.1016\/j.tranon.2017.12.006"},{"issue":"9","key":"10.1016\/j.clinimag.2025.110680_bb0055","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1016\/j.crad.2023.05.006","article-title":"Correlation of background parenchymal enhancement on breast MRI with breast cancer","volume":"78","author":"Sallam","year":"2023","journal-title":"Clin Radiol"},{"issue":"9","key":"10.1016\/j.clinimag.2025.110680_bb0060","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110680_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1200\/JOP.777003","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer","volume":"6","author":"Hammond","year":"2010","journal-title":"J Oncol Pract"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110680_bb0070","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update","volume":"138","author":"Wolff","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.clinimag.2025.110680_bb0075","series-title":"MRI Reporting-ACR BI-RADS ATLAS-BREAST MRI","year":"2013"},{"issue":"1070","key":"10.1016\/j.clinimag.2025.110680_bb0080","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160542","article-title":"Evaluation of background parenchymal enhancement on breast MRI: a systematic review","volume":"90","author":"Bignotti","year":"2017","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110680_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-022-00458-2","article-title":"MRI background parenchymal enhancement, breast density and breast cancer risk factors: a cross-sectional study in pre- and post-menopausal women","volume":"8","author":"Brooks","year":"2022","journal-title":"npj Breast Cancer"},{"issue":"1","key":"10.1016\/j.clinimag.2025.110680_bb0090","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01375-7","article-title":"Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study","volume":"22","author":"Watt","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"12","key":"10.1016\/j.clinimag.2025.110680_bb0095","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1177\/0284185120911583","article-title":"The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI","volume":"61","author":"Hellgren","year":"2020","journal-title":"Acta Radiol"},{"issue":"1078","key":"10.1016\/j.clinimag.2025.110680_bb0100","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170203","article-title":"MR imaging characteristics of breast cancer diagnosed during lactation","volume":"90","author":"Oh","year":"2017","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110680_bb0105","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.31370","article-title":"MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women","volume":"143","author":"Brooks","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinimag.2025.110680_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108818","article-title":"Correlations of female hormone levels with background parenchymal enhancement and apparent diffusion coefficient values in premenopausal breast cancer patients: effects on cancer visibility","volume":"124","author":"Jung","year":"2020","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jbi\/wbz022","article-title":"Influence of menstrual cycle timing on screening breast MRI background parenchymal enhancement and diagnostic performance in premenopausal women","volume":"1","author":"Dontchos","year":"2019","journal-title":"J Breast Imaging"},{"issue":"9","key":"10.1016\/j.clinimag.2025.110680_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003000","article-title":"Background parenchymal enhancement on preoperative magnetic resonance imaging: association with recurrence-free survival in breast cancer patients treated with neoadjuvant chemotherapy","volume":"95","author":"Choi","year":"2016","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110680_bb0130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.clinimag.2025.110680_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158573","article-title":"MRI background parenchymal enhancement is not associated with breast cancer","volume":"11","author":"Bennani-Baiti","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clinimag.2025.110680_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejrad.2019.02.018","article-title":"Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type","volume":"113","author":"Dilorenzo","year":"2019","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.clinimag.2025.110680_bb0145","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.crad.2015.02.017","article-title":"Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics","volume":"70","author":"Kim","year":"2015","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110680_bb0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-018-4916-6","article-title":"Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI","volume":"172","author":"Sung","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clinimag.2025.110680_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.breast.2022.09.007","article-title":"Mammographic breast density and the risk of breast cancer: a systematic review and meta-analysis","volume":"66","author":"Bodewes","year":"2022","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0160","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11547-010-0513-4","article-title":"Correlation between breast density in mammography and background enhancement in MR mammography","volume":"115","author":"Cubuk","year":"2010","journal-title":"Radiol Med"},{"issue":"2","key":"10.1016\/j.clinimag.2025.110680_bb0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jmri.24495","article-title":"Does MRI breast \u201cdensity\u201d (degree of background enhancement) correlate with mammographic breast density?","volume":"40","author":"Hansen","year":"2014","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejrad.2010.07.019","article-title":"Background enhancement in breast MR: correlation with breast density in mammography and background echotexture in ultrasound","volume":"80","author":"Ko","year":"2011","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.clinimag.2025.110680_bb0175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12282-021-01229-w","article-title":"Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast","volume":"28","author":"Tozaki","year":"2021","journal-title":"Breast Cancer"},{"issue":"3","key":"10.1016\/j.clinimag.2025.110680_bb0180","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00330-014-3426-0","article-title":"Intraindividual, randomized comparison of the macrocyclic contrast agents gadobutrol and gadoterate meglumine in breast magnetic resonance imaging","volume":"25","author":"Fallenberg","year":"2015","journal-title":"Eur Radiol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125002803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707125002803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:38:00Z","timestamp":1764895080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707125002803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0899707125002803"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110680","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the relationship between background parenchymal enhancement and breast cancer using 3.0\u00a0Tesla magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2025.110680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110680"}}